Follow
Xi Huang
Xi Huang
Verified email at ufl.edu
Title
Cited by
Cited by
Year
Andecaliximab/GS-5745 alone and combined with mFOLFOX6 in advanced gastric and gastroesophageal junction adenocarcinoma: results from a phase I study
MA Shah, A Starodub, S Sharma, J Berlin, M Patel, ZA Wainberg, ...
Clinical Cancer Research 24 (16), 3829-3837, 2018
802018
The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics
X Huang, MD Britto, JL Kear-Scott, CD Boone, JR Rocca, C Simmerling, ...
Journal of Biological Chemistry 289 (24), 17203-17214, 2014
612014
Phase Ib study of tirabrutinib in combination with idelalisib or entospletinib in previously treated chronic lymphocytic leukemia
AV Danilov, C Herbaux, HS Walter, P Hillmen, SA Rule, EA Kio, L Karlin, ...
Clinical Cancer Research 26 (12), 2810-2818, 2020
592020
Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease
IMS de Vera, AN Smith, MCA Dancel, X Huang, BM Dunn, GE Fanucci
Biochemistry 52 (19), 3278-3288, 2013
422013
Inhibitor-induced conformational shifts and ligand-exchange dynamics for HIV-1 protease measured by pulsed EPR and NMR spectroscopy
X Huang, IMS de Vera, AM Veloro, ME Blackburn, JL Kear, JD Carter, ...
The Journal of Physical Chemistry B 116 (49), 14235-14244, 2012
322012
A new surfactant-fluorescence probe for detecting shape transitions in self-assembled systems
L Gao, Q Song, X Huang, J Huang
Journal of colloid and interface science 323 (2), 420-425, 2008
322008
Effects of hinge-region natural polymorphisms on human immunodeficiency virus-type 1 protease structure, dynamics, and drug pressure evolution
Z Liu, X Huang, L Hu, L Pham, KM Poole, Y Tang, BP Mahon, W Tang, ...
Journal of Biological Chemistry 291 (43), 22741-22756, 2016
302016
Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts
Z Liu, TM Casey, ME Blackburn, X Huang, L Pham, IMS de Vera, ...
Physical Chemistry Chemical Physics 18 (8), 5819-5831, 2016
302016
A surfactant type fluorescence probe for detecting micellar growth
L Gao, L Zhao, X Huang, B Xu, Y Yan, J Huang
Journal of colloid and interface science 354 (1), 256-260, 2011
192011
Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational sampling
JD Carter, EG Gonzales, X Huang, AN Smith, IMS de Vera, PW D’Amore, ...
FEBS letters 588 (17), 3123-3128, 2014
162014
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
F Morschhauser, MJS Dyer, HS Walter, AV Danilov, L Ysebaert, ...
Leukemia 35 (7), 2108-2113, 2021
132021
Backbone 1H, 13C, and 15N chemical shift assignment for HIV-1 protease subtypes and multi-drug resistant variant MDR 769
X Huang, IMS de Vera, AM Veloro, JR Rocca, C Simmerling, BM Dunn, ...
Biomolecular NMR assignments 7, 199-202, 2013
112013
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of GS-5745 combined with mFOLFOX6 as first-line treatment in patients with …
JC Bendell, A Starodub, X Huang, JD Maltzman, ZA Wainberg, MA Shah
Journal of Clinical Oncology 35 (15_suppl), TPS4139-TPS4139, 2017
92017
Updated results of a phase 1 study combining the matrix metalloproteinase 9 inhibitor GS-5745 and mFOLFOX6 in patients with advanced gastric/gastroesophageal junction cancer.
MA Shah, A Starodub, J Berlin, CB Brachmann, X Huang, V Smith, ...
Journal of Clinical Oncology 35 (4_suppl), 108-108, 2017
42017
Updated results of a phase 1 study combining the matrix metalloproteinase 9 inhibitor GS-5745 with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer.
JC Bendell, MR Patel, CB Brachmann, X Huang, JD Maltzman, V Smith, ...
Journal of Clinical Oncology 35 (4_suppl), 363-363, 2017
22017
Updated Preliminary Results of a Phase 1b Dose Escalation and Dose Expansion Study of Tirabrutinib Alone or in Combination with Idelalisib or Entospletinib in Patients with …
AV Danilov, C Herbaux, MJS Dyer, P Hillmen, S Rule, EA Kio, X Huang, ...
Blood 132, 3135, 2018
12018
Updated Preliminary Results of a Phase 1b Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination with Idelalisib in Patients with B-Cell Lymphoma
F Morschhauser, J Radford, L Ysebaert, SE Spurgeon, EA Kio, G Salles, ...
Blood 132, 5345, 2018
2018
Updated Preliminary Results of a Phase 1b Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination with Entospletinib in Patients with B-Cell Lymphoma
G Salles, MJS Dyer, DJ Hodson, K Bouabdallah, L Ysebaert, G Cartron, ...
Blood 132, 5344, 2018
2018
Conformational sampling and non-dimer aggregates of HIV-1 protease containing darunavir promoted mutations
L Pham, Z Liu, L Hu, X Huang, A Bhatt, K Bentz, T Tran, D Savin, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017
2017
Results of a phase I study of GS-5745 in combination with gemcitabine and nab-paclitaxel in patients (pts) with advanced pancreatic cancer.
JC Bendell, X Huang, V Smith, JD Maltzman, A Starodub
Journal of Clinical Oncology 34 (15_suppl), e15683-e15683, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20